​You're invited as a guest of The Frontier Syndicate. Admission is complimentary for our community — approval required, capacity limited.

​The longevity conversation is stuck on one number: how long we live. The more valuable question is how long we stay healthy, capable, and mentally sharp.

​The gap between those two numbers is where the science is. And where the market is going.

​Dr. Nikolay Dokholyan came to this question from physics — Harvard biophysics training, now Tucker Professor of Neurology at UVA School of Medicine, 370+ peer-reviewed papers, seven patents, two biotech companies founded, and Senate testimony on the fiscal reality of the Alzheimer's crisis.

​His keynote walks through what actually breaks as we age — and why these systems fail together rather than separately. Then the part most longevity talks skip: how understanding becomes therapy, and how therapy becomes a company, through his lab's drug discovery platforms DRIFT and CANDI. And where precision health, therapeutics, and longevity science create white space for new products, companies, and capital.

​This is Tech Flow's inaugural Bay Area gathering — a community of 1,000+ entrepreneurs and professionals building companies in the US, hosted with Digital October. We're bringing a curated group of researchers, founders, and investors from the Frontier community to be in the room.

​Agenda

​6:00 PM — Registration and welcome networking
6:25 PM — Host welcome
6:30 PM — Keynote: Dr. Nikolay Dokholyan
7:00 PM — Lightning introductions around the room
7:45 PM — Networking party — dinner, drinks, and photography

​What's included

​Keynote session, dinner and beverages (beer, wine, non-alcoholic), professional photography shared within 48 hours, and access to the Tech Flow community.

​About the speaker

​Dr. Nikolay Dokholyan is the Weir M. and Linden C. Tucker Professor of Neurology at the University of Virginia School of Medicine, where he leads the Center for Health Intelligence. Trained as a physicist before moving into biology, he has published over 370 peer-reviewed papers, founded two biotech companies, and serves as Editor-in-Chief of Proteins.

He is a Fellow of the American Physical Society, the AAAS, and the American Institute for Medical and Biological Engineering, and has testified before the U.S. Senate on the Alzheimer's crisis. His lab works on neurodegeneration, computational drug discovery, and AI-driven therapeutic design.

​Who should attend

• ​Researchers working on aging biology, computational drug discovery, or AI-driven therapeutic design

• ​Founders building in precision health, diagnostics, therapeutics, or longevity

• ​Investors evaluating where healthspan science becomes venture-scale opportunity

• ​Engineers applying ML and computational methods to biology and drug development

​Capacity is limited. Registration is subject to approval.

​We will take photos and short video clips for event recap and promotion. By attending, you consent to being photographed and recorded, and to the use of those images and clips by the organizers on social media and other event marketing channels.

​Hosted by

​Digital October is a center for technology entrepreneurship — convening founders, researchers, and investors around new technologies and the companies built on them, through conferences, educational programs, and events with global experts. (Sponsor of this event.)

​TechFlow (joinTechFlow.com) is a community of 1,000+ entrepreneurs and professionals building careers and companies in the US — builders who show up. Founded in 2023, TechFlow hosts in-person gatherings across 14 cities, bringing together founders, engineers, product and marketing professionals, and investors. (Info partner.)

​The Frontier Syndicate is a research-native venture network connecting frontier technology researchers, builders, and investors through curated convenings and early-stage capital. Across the Bay Area, we host recurring research forums, builder nights, and private investor dinners — and back exceptional companies emerging from the technical networks we convene.